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Abstract : The growing recognition of care fragmentation is causing many
countries to explore new approaches to healthcare delivery that can bridge
the boundaries between professions, providers and institutions and so better
support the rising number of people with chronic health problems. This paper
examines the role of the regulatory, funding and organisational context for
the development and implementation of approaches to chronic care, using
examples from Austria, Germany and the Netherlands. We find that the three
countries have implemented a range of policies and approaches to achieve
better coordination within and across the primary and secondary care interface
and so better meet the needs of patients with chronic conditions. This has
involved changes to the regulatory framework to support more coordinated
approaches to care (Austria, Germany), coupled with financial incentives
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(Austria, Germany) or changes in payment systems (the Netherlands). What is
common to the three countries is the comparative ‘novelty’ of policies and
approaches aimed at fostering coordinated care; however, the evidence of their
impact remains unclear.
1. Introduction
The rising number of people with chronic conditions presents challenges for all
health systems. In the European Union, in 2006, between 20% to over 40% of
the population aged 15 years and over reported a long-standing health problem
and one-fourth currently receives medical long-term treatment (TNS Opinion
and Social, 2007). The complex nature of many chronic health problems
requires a delivery system that involves coordinated inputs from a wide range of
health professionals over an extended period of time and that places patients at
the centre as co-producers of care to optimise health outcomes (Nolte and
McKee, 2008a, 2008b). Yet, service delivery has developed in ways that have
tended to fragment care, both within and between sectors, through, for example,
structural and financial barriers dividing providers at the primary/secondary
care and at the healthcare and social care interface (Glasby et al., 2006).
The growing recognition of this fragmentation is causing many countries to
explore new approaches to healthcare delivery that can bridge the boundaries
between professions, providers and institutions and so provide appropriate support
to patients with long-standing health problems. Key elements suggested to address
fragmentation include improved collection and sharing of information, moving care
into the community and aligning payment schemes to incentivise care coordination
and enhance integration of provision of services (Hofmarcher et al., 2007). How-
ever, countries vary in their attempts to do so and approaches that are being
implemented reflect the characteristics of individual health systems as they relate to
the relationships between, and responsibilities of, different stakeholders in the
regulation, funding and delivery of health care (Nolte et al., 2008).
This paper discusses some of the key approaches to overcoming fragmentation
in health care, with a particular focus on the role of the regulatory, funding and
organisational context for the development and implementation of approaches
to chronic care. We illustrate these approaches with examples from Austria,
Germany and the Netherlands.
Our analysis is based on a review of the published and grey literature, com-
plemented by data collected within the DISMEVAL project (Developing and vali-
dating DISease Management EVALuation methods for European healthcare systems),
using a common data collection template which is described in detail elsewhere
(RAND Europe and London School of Hygiene and Tropical Medicine, 2011).
In order to contextualise chronic care development in each country, we provide a
concise overview of selected features of the country’s health systems. We describe
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the key regulatory and policy measures making possible current chronic care
strategies, highlighting some of the main approaches to overcoming fragmen-
tation in chronic care and reviewing the documented evidence of their impact.
2. Background on chronic care in Austria, Germany and
the Netherlands
The implementation of chronic care policies in Austria, Germany and the
Netherlands has to be understood in the overall context of healthcare govern-
ance and organisation. The three healthcare systems are principally based on the
Bismarckian model of statutory health insurance (SHI), characterised by a
universal, mandatory insurance scheme with responsibility for the healthcare
system shared by government (central and state governments in Austria and
Germany) and corporatist actors. More recently, the three systems have followed
different paths, in particular with regard to the introduction of market elements
into the system. In brief, in 1993, Germany introduced free choice of SHI (Busse
and Riesberg, 2004), whereas the Netherlands moved to a mandatory, regulated
private insurance system with competing private insurance funds in 2006 (Scha¨fer
et al., 2010). In Austria, competition among health insurers, although discussed,
has so far not been pursued (Hofmarcher and Rack, 2006). In terms of the pro-
vision of health care, the Netherlands is unique among SHI systems in western
Europe in that general practitioners (GPs) act as gatekeepers to specialist care, a
characteristic feature maintained after the 2006 reform (Scha¨fer et al., 2010). In
contrast, Austria and Germany principally allow for free choice of office-based
generalist and specialist care providers outside hospital (Busse and Riesberg,
2004; Hofmarcher and Rack, 2006). Table 1 provides an overview of selected
characteristics of healthcare governance and provision in each country.
3. The evolution of chronic care policies
Care fragmentation, particularly at the boundary between primary and sec-
ondary care, has been a main concern in all three countries, and it has prompted
a series of various regulatory measures and activities (Table 2). However, the
pace, breadth and depth with which relevant initiatives and policies have been
implemented have varied.
Thus, in Germany, provisions to support more integrated models of care were
introduced as early as 1993, subsequently strengthened by the 2000 SHI Reform
Act and the 2004 SHI Modernisation Act, which removed certain legal and
financial obstacles towards better integration (Busse and Riesberg, 2004). In
parallel, in 2002, the government introduced structured care programmes for
those with chronic disease, frequently referred to as ‘disease management pro-
grammes’ (DMPs), in an explicit effort to provide insurers and providers with
incentives to encourage evidence-based chronic care (Siering, 2008). Defined as
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Table 1. Selected features of healthcare systems in Austria, Germany and the Netherlands
Austria Germany The Netherlands
Health expenditure (2008)
% GDP 10.5 10.5 9.9
Per capita expenditure (US$ PPP) 3970 3737 4063
Main sources of financing (2008) SHI: 44.1% SHI: 67.9% *SHI: 70.2%
Taxation: 32.8% Taxation: 8.8% Taxation: 5.1%
OOP: 15.1% OOP: 13.0% OOP: 5.7%
VHI: 4.5% VHI: 9.5% VHI: 5.6%
Governance of the public health system
Principle responsibilities Shared by central government,
nine state governments and
corporatist actors; responsibility
for hospital sector mainly with the
federal states
Shared by central government, 16
state governments and corporatist
actors; responsibility for hospital
sector mainly with the federal
states
Shared by federal and local
authorities and corporatist actors
Main supervisory/regulatory body
independent of government (year
established)
Federal Health Agency
(Bundesgesundheitsagentur, 2005);
separate legal entity responsible for
developing the framework for
planning health service provision
in all sectors, management of the
interface between sectors;
development of performance-
orientated reimbursement systems
in all healthcare sectors
Federal Joint Committee
(Gemeinsamer Bundesausschuss,
G-BA, 2004); decision-making
body in SHI system; sets legal
framework for healthcare
provision, issues binding
directives, develops
recommendations for DMPs,
develops quality assurance
measures for ambulatory, hospital
and integrated care
Dutch Health Care Authority
(Nederlandse Zorgautoriteit, NZa,
2006); responsible for monitoring
and administering the markets for
health care provision, health
insurance and the purchasing of
health care; oversees the lawful
implementation of the Health
Insurance Act and Exceptional
Medical Expenses Act
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Principles of healthcare provision outside
hospital
Provision of primary/generalist and
specialist care outside hospital
Office-based primary and specialist
care physicians; outpatient clinics
Office-based primary and specialist
care physicians
GPs in group practices
Choice of provider in primary/
ambulatory care
Yes Yes Yes; registration with GP required
GP gatekeeping No Voluntary (‘GP contracts’) Yes; access to specialist care upon
referral only
Payment of physicians in primary/
ambulatory care
Blended system of fee-for-service
with capitated element for basic
services; determined by payment
schemes based on public services
or private law and supplemented
by bonuses defined by the state
Combination of capitation and fee-
for service based on centrally
negotiated ‘uniform value scale’
(EBM) by the Federal Association
of SHI physicians and the National
Association of SHI Funds
Combination of capitation and fee-
for-service; maximum
remuneration fees for GPs
negotiated between National
Association of GPs, Health
Insurers Netherlands and Ministry
of Health, Welfare and Sport
Payment of hospitals Performance-oriented hospital
financing system (LKF; 1997)
G-DRG (phased in from 2003) Diagnosis and treatment
combinations (DBCs; 2005)
PPP, purchasing power parity; SHI, statutory health insurance; OOP, out-of-pocket payment; VHI, voluntary health insurance; DBCs, Diagnosis and treatment
combinations; DMPs, disease management programmes; EBM, Einheitlicher Bewertungsmassstab; GPs, general practitioners; LKF, Leistungsorientierte Kran-
kenanstaltenfinanzierung; G-DRG, German diagnosis-related groups.
Sources: Busse and Riesberg (2004); Ettelt et al. (2006); Hofmarcher and Rack (2006); OECD (2010); Scha¨fer et al. (2010)
Notes:*According to figures from the Dutch statistical office, in 2009, SHI accounted for 68% of GDP and taxation for 13%, with the remainder including
OOP (,9%) and VHI (4%) (Centraal Bureau voor de Statistiek, 2009).
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Table 2. Overview of the regulatory framework for chronic care policies and approaches
implemented during the 2000s in Austria, Germany and the Netherlands
Country Title of reform/regulation Stated aim/s of reform/regulation
Austria 2005 Health Reform Act Established state health funds (Landesgesundheitsfonds,
2006); created financial pool at state level (Reform
pool) as a means to promote coordination of and
cooperation between ambulatory and hospital
care; established Federal Health Agency; introduced
e-card and made provisions for planing and
accordance of electronic patient record by
introducing the Health Data Transmission Law
(Gesundheitstelematikgesetz)
2008 Agreement according to
Federal Constitution Article
15a on the Organisation and
Financing of the Healthcare
system 2008–2013
Commits to continue and develop further measures
implemented with the 2005 reform including
(among others) the integrated planning of health
services across sectors; the implementation of needs-
and patient-centred pilot projects in ambulatory care
and the strengthening and further development of
the reform pool to support chronic care approaches
2010 Act to Strenghten
Ambulatory Care
Introduced right for physicians to establish group
practices (‘ambulatory care centres’) as limited
liability company
Germany 2000 SHI Reform Act Introduced provisions for the development of
integrated care structures between the ambulatory
care and hospital sector; required SHI funds to set
aside a defined amount pr member for primary
prevention or health promotion activities
2001 Risk Structure
Compensation Reform Act
Introduced, from 2002, structured care programmes
for those with chronic disease (disease management
programmes) into the German healthcare system
2004 SHI Modernisation Act Established Federal Joint Committee; strengthened
integrated care and GP-centred care (through GP
contracts); introduced medical care centres which
provide care across several healthcare specialities
within the ambulatory care sector
2007 Act to Strengthen
Competition within SHI
Made health insurance mandatory for all and
introduced the morbidity-adjusted risk
compensation scheme with effect from 2009
2008 Long-term Care Reform
Act
Enabled delegation of selected medical tasks to non-
medical staff in the framework of pilot projects
2008 Act on the Advancement
of Organisational Structures
within SHI
Further strengthened provisions for GP-centred care
Netherlands 2006 Health Insurance Act Established single mandatory insurance system;
introduced possibility of selective contracting with
collectives to target care delivery to those with
chronic conditions
2007 Social Support Act Introduced provisions to enable chronically ill and/
or disabled people to live independently and
participate in society
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‘the coordinated treatment and care of patients during the entire duration of a
(chronic) disease across boundaries between providers and on the basis of scientific
and up-to-date evidence’ (Bundesversicherungsamt, 2011), DMPs became the
predominant approach to chronic illness care in Germany. Subsequent reforms
introduced additional measures to strengthen coordination within the ambulatory
care sector, most notably the 2004 introduction of GP-centred care and of medical
care centres or policlinics (Ettelt et al., 2006), and provisions to enable the use of
non-medical staff in chronic illness care from 2008 (Fullerton et al., 2011).
The Netherlands, in the 1990s, saw the introduction of the concept of shared
care, based on the principle of cooperation and coordination between generalist
and specialist caregivers with shared overall responsibility (Linden, 2000).
Although spreading rapidly throughout the 1990s, lack of sufficient funding
challenged their viability and sustainability. From the 2000s, disease manage-
ment approaches received growing interest (Vrijhoef et al., 2001), but uptake
remained limited (Steuten et al., 2002), mainly because of a lack of a structured
framework (Klein-Lankhorst and Spreeuwenberg, 2008). More recently, the
2006 health insurance reform, which granted insurers extended powers to
negotiate with provider organisations, facilitated the development of new forms
of service delivery and payment for more integrated care. This involved the
initially diabetes-focused establishment of GP-formed ‘care groups’ who con-
tract with health insurers on the basis of a ‘bundled payment’ for a defined
package of diabetes care (Struijs et al., 2010). This was strengthened by the
2008 ‘Programmatic approach to chronic illness care’ and proposals to generally
fund chronic care through bundled payment schemes, accompanied by regulatory
measures to strengthen the role of nurses in the care of the chronically ill (Table 2;
Scha¨fer et al., 2010).
In Austria, activities to strengthen more integrated provision of care have been
a more recent phenomenon, with the 2005 health reform contributing to the
development of related approaches (Hofmarcher and Rack, 2006). It estab-
lished, in 2006, the State Health Funds in each of Austria’s nine federal states
Table 2. (Continued)
Country Title of reform/regulation Stated aim/s of reform/regulation
2009 Act for Allowances for
the Chronically Ill and
Handicapped Persons
Introduced entitlement for the chronically ill and
disabled persons to receive a fixed allowance to
compensate for excessive healthcare expenses
2009 Amendment of the 1993
Individual Health Care
Professions Act
Facilitated use of nurses in the care of chronically ill
and elderly people, enabling clinical nurse specialists
with set qualifications to autonomously perform
common and minor medical procedures
SHI: statutory health insurance; GP, general practitioner.
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and created a financial pool at state level (Reform pool), which combines funds
from SHI and regional governments to finance projects that coordinate health-
care delivery across sectors, in particular between ambulatory and hospital care.
These ‘reform pool projects’ have formed the basis for the majority of current
approaches to chronic care in Austria, most frequently disease management pro-
grammes. Other efforts have aimed, since 2007, to establish ambulatory care
centres to enhance integration of service delivery, particularly for those with chronic
illness (Eichwalder and Hofmarcher, 2008). This was part of a wider policy
development including the conclusion of agreements between the medical profes-
sion and health insurance funds to establish group practices, and the 2008–2013
government programme that made improving patient access to ambulatory care
services a priority as part of an overall move to increase the effectiveness and
efficiency of integrated healthcare services in the Austrian healthcare system
(Hofmarcher and Hawel, 2010).
4. Approaches to chronic care
The regulatory and policy measures facilitated the implementation of chronic
care approaches. This section describes in more detail the key features of
approaches pursued in each of the countries, focusing on commonalities and
differences between countries. As indicated above, the overarching care model
tends to be a form of disease management, whose main characteristics as they
relate to funding mechanisms, distribution and uptake, alongside principles of
provider and patient participation and the coordination process are summarised
in Tables 3 and 4.
4.1 A focus on single chronic conditions
Most approaches pursued in all three countries tend to be disease-specific, with
type 2 diabetes most typically targeted. The focus on diabetes is perhaps not
surprising, given the disease and cost burden associated with this condition
worldwide (Pomerleau et al., 2008). However, a focus on diabetes was also
prompted by existing examples of care models that could be drawn upon. For
example, in the Netherlands, the development of diabetes care groups was greatly
informed by a care model developed in Maastricht, the Maastricht Transmural
Diabetes Organisation, which originates from the 1990s (Klein-Lankhorst and
Spreeuwenberg, 2008). In Austria, the diabetes DMP was modelled, in part, on the
disease management programme for type 2 diabetes developed in Germany. Other
diseases targeted include cardiovascular disease, chronic respiratory disease and
breast cancer (Germany).
However, the focus on single diseases has been identified as a concern, given
the often multiple health problems among people with chronic conditions. In an
attempt to address this, regulation in Germany has mandated the development
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Table 3. Features of the principal approach to chronic care in Austria, Germany and the Netherlands: target population, funding, distribution and uptake
Approach Aim/general description Target population
Year
implemented Funding
Use of financial
incentives Distribution and uptake
Austria
Diabetes DMP
(Therapie
Aktiv)
To improve the quality
of life and extend life for
people with chronic
disease, to place the
patient at the centre of
care and to make
efficient use of
healthcare resources and
also reduce
hospitalisations
Type 2 diabetes 2006 Regional SHI fund
and federal state
contribute , 50%
each; programme
development funded
by regional SHI funds
DMP physicians:
patient sign-up and
quarterly fee for
treatment and
documentation
Implemented in five of nine
states; two states operate
separate programmes, one of
which is to be integrated into
Therapie Aktiv
Approximately17,000
patients are enrolled in the
DMP across Austria
(, 4.3% of all people with
type 2 diabetes)
Germany
DMP Organisational approach
to medical care that
involves the coordinated
treatment and care of
patients with chronic
disease across boundaries
between individual
providers on the basis of
scientific and up-to-date
evidence
Types 1 and 2 diabetes,
coronary (plus chronic
heart failure), breast
cancer, asthma/chronic
obstructive pulmonary
disease (COPD) (obesity
module in preparation)
2003 Funded from usual
sources (SHI)
DMP physicians:
additional payment
for documentation
and education
DMPs are offered by SHI
funds, with , 2000 DMPs
for each condition (2010);
number of participating
physicians varies, , 65% of
GPs act as DMP physician
for type 2 diabetes
Patients: may be
exempted from
practice fee
By the end 2010, a total of
5.75 million individuals were
enrolled in one or more
DMPs, from 127,700 in
breast cancer DMP to , 3.4
million in type 2 diabetes
DMP (approximately two-
thirds of diagnosed diabetics
in the SHI system)
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Table 3. (Continued)
Approach Aim/general description Target population
Year
implemented Funding
Use of financial
incentives Distribution and uptake
Netherlands
Bundled
payment
contract (‘care
group’)
To facilitate
multidisciplinary
cooperation through
the elimination of
existing financial
barriers between
providers and sectors
based on nationally
defined care standard
that encompasses
prevention, early
detection, treatment and
rehabilitation
Type 2 diabetes,
vascular risk, chronic
obstructive pulmonary
disease, heart failure
(under development)
2007
(diabetes)
Funded from usual
sources (mandatory
insurance) on the
basis of a bundled
payment contract
Physicians: bundled
payment for defined
package of care
Insurer: to negotiate
low price for care
chain
There were 97 care groups
in March 2010 holding a
bundled payment contract
with a health insurer,
mostly for diabetes care;
there are relatively few care
groups for the provision of
vascular risk management;
of 55 care groups surveyed
in early 2010, two had a
bundled payment contract
in place for vascular risk
management, whereas 17
were preparing to contract
DMP, disease management programme; SHI, statutory health insurance.
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Table 4. Features of the principal approach to chronic care in Austria, Germany and the Netherlands: participation, principles of care coordination and
patient self-management support, use of information systems
Name Participation: provider Participation: patients Care coordination
Self-management
support
Use of information
systems
Austria
Therapie Aktiv
DMP
Principally offered by
regional SHI fund based on
contracts between regional
SHI fund and providers
Participation is voluntary
for providers who have to
attend mandatory provider
training to be accredited as
DMP physician; annual
advanced training sessions
and quality circles
Participation is
voluntary
Patients chose physician
who participates in the
DMP and acts as
coordinating physician
(usually family
physician/GP)
Eligibility for
participation is
determined based on
presence of diabetes
DMP physician oversees
referral between levels
of care according to care
pathways developed by
the Austrian Society of
Diabetes and ensures
regular follow-up
Patient education
through group
instruction courses
provided by DMP
physician or diabetes
advisors/specialists
Patient involvement in
determining therapeutic
goals and timelines,
with agreed targets
signed jointly
Standardised
documentation of
clinical and diagnostic
measures and treatment;
nationwide monitoring
is planned but regular
feedback reports to
participating physicians
have yet to be
implemented
Germany
DMPs Principally offered by SHI
funds based on collective
contracts between funds
and providers at regional
level
Participation is voluntary
for providers who have to
meet defined training
standards and may have to
attend further training and/
or quality circles on a
regular basis
Participation is
voluntary for patients
Patients chose physician
who participates in the
DMP and acts as
coordinating physician
(usually family
physician/GP)
Eligibility for
participation is
determined based on
presence of chronic
condition
Patient management
comprises coordination
of three care levels
(coordinating physician,
specialised outpatient
care and inpatient care)
according to conditions
for referral set out in
regulation. DMP
physician ensures
regular patient follow-
up
Obligatory patient
education programme
(approved by the
Federal Insurance
Office) provided by
DMP physician or local
training centre
Patient involvement in
determining therapeutic
goals and timelines
Telephone-based
support provided by
some SHI funds
Standardised electronic
documentation of
treatment, patient’s
condition and test
results, medication
regime and agreed
treatment goals;
centralised data analysis
to produce quality
reports and provider
feedback on
performance and for
benchmarking
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Table 4. (Continued)
Name Participation: provider Participation: patients Care coordination
Self-management
support
Use of information
systems
Netherlands
Bundled
payment
contract
(‘care group’)
(e.g. Heuvelland
diabetes care
group)
Offered by care group who
contracts with health
insurers providing a
package of care defined by
national standards
Care group contracts with
and/or employs providers
(GPs, specialists, allied
staff); Heuvelland diabetes
care group brings together
all GPs in the region
(Maastricht)
Patients join programme
through GP they are
registered with
Patients are stratified
according to disease
severity into four
regular modules plus
two modules for
(complex) problems. GP
acts as central
coordinator, supported
by practice and
specialised nurses
responsible for care
management
GP oversees referral to
secondary care
according to defined
criteria and ensures
follow-up
Regular check-ups
include education on
self-management by
practice nurses/
specialised diabetes
nurses, depending on
the level of need; level of
need defines frequency
and duration of
consultations to be
conducted for
educational purposes
Disease-specific
electronic patient record
(‘MediX’) contains
check-up and referrals
data within care
programme, allows for
information sharing and
automatisation of care
protocols, can be linked
to laboratory data and
functional
measurements
DMP, disease management programme; SHI, statutory health insurance; GP, general practitioner.
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of additional disease management modules for obesity and chronic heart failure
to supplement existing DMPs (Siering, 2008). In the Netherlands, a framework
to address overweight and obesity within the care group approach is being
developed (Partnership Overweight Netherlands, 2009).
Approaches addressing a wider spectrum of needs, including those arising
from multiple conditions, frequently centring on populations aged 65 years and
above (here referred to as ‘generalist’ approaches) have also been introduced but
have as yet remained geographically localised and/or restricted to pilot pro-
grammes.
4.2 Conceptualisation of ‘disease management’ as a means to strengthen
care coordination
The overarching approach to strengthen care coordination is through some form
of disease management although the content and scope of related approaches
differs considerably between the three countries. Thus, the care groups in the
Netherlands have been conceived as a multidisciplinary team approach with a
physician (‘director’) overseeing the overall coordination between the various
participating care providers, whereas patient management is, to great extent,
delegated to nurses (Table 4). In contrast, in Germany and Austria, disease
management has remained very much within the traditional structure of care
provided by doctors within the ambulatory care sector, although following a
strict protocol overseeing the patient management between levels of care, and in
which non-medical staff (typically confined to practice assistants) play, if any-
thing, a small role. Indeed, the use of non-medical staff such as specialised
nurses or practice assistants Austria and Germany is a fairly recent phenom-
enon. Examples include GP contracts in Germany (Fullerton et al., 2011) or
home care for patients with chronic heart failure in Salzburg, Austria (Arbeit-
skreis Vorsorgemedizin Salzburg, 2010). In Germany, services provided by non-
medical staff may include monitoring; the assessment of mental, physical or
psychological problems; and coordination with other service providers. How-
ever, by law, all services must be assigned and performed under the supervision
of the GP (Bewertungsausschuss nach y 87 Abs. 1 Satz 1 SGB V, 2009).
4.3 Incentivising the implementation of care coordination
Several approaches use financial incentives, usually targeted at physicians
although funders have also benefitted from additional (time limited) resources
earmarked for care coordination and integration initiatives. For example, in
Germany, to make disease management programmes an attractive option for the
SHI funds, their introduction was linked to the risk structure compensation
scheme (RSA). This provided SHI funds with a substantial financial incentive to
offer DMPs as part of their portfolio of services and to motivate their members
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to take part in these programmes. This strategy had considerable success: by
October 2009 SHI funds offered over 13,300 DMPs and a total of 5.5 million
patients had signed up to at least one DMP (Bundesversicherungsamt, 2007).
However, since 2009, following a reform of the RSA scheme with the introduction
of a morbidity-adjusted RSA, the financial incentive for SHI funds has been reduced
markedly, and numbers of patients signing up for DMPs have been stagnating since
(Fullerton et al., 2011). Whether this stagnation reflects a saturation effect or is a
consequence of the reduced financial incentive is as yet unclear.
At the same time, SHI funds were also given the possibility to designate
financial resources, of a total of 1% of their income, for selective contracting
with single providers or network of providers (Busse and Riesberg, 2004). The
nature and scope of integrated care contracts has varied, with many focusing on
the interface between acute hospital and rehabilitative care. By the end of 2008,
approximately 6400 integrated care contracts had been concluded, covering
, 6% of all SHI insured. However, by the end of 2008, when the financial
incentive was concluded, less than half of these contracts had incorporated
elements of intersectoral care (Sachversta¨ndigenrat zur Begutachtung der
Entwicklung im Gesundheitswesen, 2009).
In the Netherlands, the bundled payment scheme is based on the principle of a
care group (zorggroep), a legal entity that brings together providers (mostly
GPs) in primary care. As the principal contractor, the care group enters into a
contract with a health insurer to provide a package of care for a given condition
according to a nationally developed care standard (‘bundled payment contract’).
The price for the package of care is negotiated between the provider care group
and the insurance fund on the basis of the performance of the care group.
Conceived as an ‘experiment’ in 2006, with 10 diabetes care groups receiving
start-up funding for a period of 16 months and accompanying evaluation
(Struijs et al., 2010), the government subsequently decided to roll-out this
strategy nationally for the delivery of care for patients with diabetes, chronic
obstructive pulmonary disease (COPD) or vascular risk (Vrijhoef, 2010).
However, although diabetes contracts have achieved national coverage, the
negotiation of a bundled payment for COPD and vascular risk management has
remained a challenge (Van Til et al., 2010).
In Austria, as noted earlier, the reform pool made it possible to explicitly fund
projects in integrated care, including disease management programmes descri-
bed above, as well as a wide range of other approaches such as various forms of
case management including managed discharge (Czypionka et al., 2008) or
integrated care for stroke patients (Hofmarcher et al., 2007). However, imple-
mentation of reform pool activities has been uneven across states and related
projects have been slow to take off partly because of a lack of financial incen-
tives for physicians to participate in such projects. There has been limited federal
oversight of the reform pool funds and projects, leading to duplication of efforts
and a lack of scale-efficiency in some regions. The highest number of projects
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was funded in 2007 (23), at a cost of h11 million, but project activity fell
subsequently. Of all funds available, only 16% had been put to use, but this
varied greatly by region with over 30% used in Styria and only 1.5% in Tyrol
(Czypionka and Ro¨hrling, 2009).
4.4 Encouraging uptake of programmes by patients and providers
In all three countries, participation in the coordinated care approaches is
voluntary for physicians and patients, and they are funded within the statutory
system, thus making them principally available to all eligible patients. However,
coverage is varied, in the case of diabetes care programmes ranging from some
4.3% of the population with type 2 diabetes in Austria (O¨sterreichische Diabetes
Gesellschaft, 2010) up to ,60% in Germany (Scha¨fer et al., 2010a, 2010b). In the
Netherlands, approximately two-thirds of an estimated 750,000 people with dia-
betes are covered by a bundled payment contract (Van Til et al., 2010).
The comparatively low uptake in Austria partly reflects variation in avail-
ability of relevant programmes across the different states, which, in turn, reflects
variation in the participation rates of primary care physicians in such programmes
(Therapie Aktiv Diabetes im Griff, 2011), ranging from an estimated 16% in
Lower Austria and Vienna to 36% in Salzburg (authors’ estimates based on Habl
and Bachner (2010)). Low participation may reflect physicians’ resistance to the
(perceived or real) additional administrative burden imposed by DMPs.
The administrative burden caused by documentation requirements was initially
also a concern for physicians in Germany, following the introduction of DMPs
(Siering, 2008); processes have since been simplified. In Germany, ,65% of GPs
participate in the diabetes DMP, which may be explained by financial incentives
offered to participating physicians. In the Netherlands, participation rates of GPs in
structured care programmes are likely to be higher, with relevant incentives inherent
in the structure of the bundled payment contract, offering considerable means to
negotiate prices. Participation is estimated at 77% of all GPs (Van Til et al., 2010)
and is likely to increase further with government plans to move all care for diabetes
(and other chronic conditions) to bundled payment contracts.
5. What has the impact been?
The preceding sections have demonstrated how all three countries reviewed here
have implemented a range of policies and approaches to achieve better coor-
dination within and across the primary and secondary care interface and so
better meet the needs of patients with chronic conditions. This has involved
changes to the regulatory framework to support more coordinated approaches
to care (Austria, Germany), coupled with financial incentives (Austria, Germany) or
changes in payment systems (the Netherlands). What is common to the three
countries, as indeed in most other OECD countries (Hofmarcher et al., 2007), is the
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comparative ‘novelty’ of policies and approaches aimed at fostering coordinated
care, and the evidence of their impact remains unclear.
In Germany, evidence from the statutory evaluation of diabetes DMPs points
to improved quality of care for participating patients (Scha¨fer et al., 2010a,
2010b). The few existing controlled studies provide limited evidence of
improved outcomes, such as quality of life (Ose et al., 2009) and mortality
(Miksch et al., 2010; Stock et al., 2010) as well as reduced costs (Stock et al.,
2010). However, the extent to which improved survival can indeed be attributed
to the diabetes DMP remains uncertain (Miksch et al., 2010; Scha¨fer et al.,
2010a, 2010b), with other studies failing to provide evidence of improved
medical outcomes (Linder et al., 2011). In addition to methodological chal-
lenges, a major question remains as to whether disease-specific approaches such
as the German DMPs are suited to meet the needs of the typical patient in
primary care who frequently has multiple health problems with complex needs
(Fullerton et al., 2011). More general approaches such as integrated care con-
tracts or policlinics might potentially be better equipped to respond to more
complex patient needs, yet evidence of their effect within the German healthcare
system remains poorly understood because of lack of systematic evaluation.
In Austria, the phasing-in of DMPs was accompanied by evaluation in almost
all federal states. For example, the diabetes DMP Therapie Aktiv, implemented
in Salzburg, was evaluated using a cluster-randomised controlled trial. The evidence
was mixed, however, with non-significant improvements in metabolic control, the
main clinical outcome, although other measures (weight and cholesterol) improved
significantly (So¨nnichsen et al., 2010). Improved process measures were also
observed for the diabetes DMPs implemented in Lower Austria, for example,
demonstrating a reduction in hospital utilisation among those enrolled in a DMP
pointing to the potential for cost savings although the overall evidence for DMPs to
actually do so has remained inconclusive (Ruh et al., 2009).
In the Netherlands, findings from the evaluation of the first year of the 10
‘experimental’ diabetes care groups found wide variation in number and type of
participants, the content of the packages of care covered, and price (between
h258 and h474 per patient per year) (Struijs et al., 2010). Thus, contracts differed
in the extent to which they offer additional services beyond the core package of
care, such as smoking cessation guidance and/or foot care. Importantly, as the
precise content of care is not clearly defined, there is a risk of ‘double-billing’ of
selected care components, although the extent to which this is happening in practice
is unknown. Evidence of impact on outcomes has remained inconclusive thus far.
An expectation that diabetes care groups will, through improving the quality of
(diabetes) care, lead to cost reductions could not be verified at 12-month follow-up;
indeed, although costs might be saved due to reduced hospitalisations, they may
at the same time increase because of ‘intensification’ of care for diabetic patients
(Struijs et al., 2010), an observation that was also made for selected DMPs in
Austria (Ruh et al., 2009).
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6. Discussion
In this paper, we have traced the evolution of chronic care in Austria, Germany
and the Netherlands, all of which are principally financed from SHI. We find
that countries have implemented a range of policies and approaches to overcome
fragmentation in the healthcare system to achieve better coordination within
and across the primary and secondary care interface and so better meet the
needs of those with chronic conditions. A predominant model of care in the
form of structured disease management has emerged in all three countries,
although the evolution of these models has differed. Thus, in Germany, disease
management was introduced in a top-down process, using a regulatory frame-
work to ensure nationwide implementation (Siering, 2008). The Dutch model,
although implemented nationwide upon government initiative, evolved from an
experiment with a limited set of providers and informed by earlier experience of
a delivery model developed in the 1990s (Klein-Lankhorst and Spreeuwenberg,
2008). In Austria, disease management programmes were made possible within the
framework of a new financial instrument at the level of federal states, with states
introducing such approaches broadly modelled on German DMPs. However,
programmes have been slow to take off because projects require additional funds,
and therefore disincentivising project approval (Hofmarcher et al., 2007).
Recent reforms in Austria have attempted to shift supply from inpatient to
outpatient settings and improve patient access to ambulatory care services.
However, these reforms have been restricted to physicians and are yet to take off in
practice. Overall, this highlights the challenges experienced in Austria to arriving at
an overarching strategic approach in a system that involves multiple actors in the
negotiation of ambulatory care, including 21 SHI funds, the Federation of Austrian
Social Security Institutions, the Austrian Medical Association and associations of
other health professions (Hofmarcher and Rack, 2006). One area where the central
government has taken a clear position is in efforts to promote a more integrated
approach to planning, which is now being pursued towards coordinated supply
across healthcare sectors.
In Germany, in contrast, while also involving multiple actors, negotiations
relating to the ambulatory care sector are centralised at the national level (Busse
and Riesberg, 2004), which may have facilitated the development of a national
framework. However, it should be noted that the introduction of DMPs was
strongly supported by SHI funds such as the general regional funds, which,
because of their member profile, were disadvantaged by the RSA and their
national association took a leading role in the promotion of the programmes.
The government was also very supportive of swift implementation of DMPs and
it took provisions to do so despite resistance from many stakeholders.
At the same time, although the creation of a strict national regulatory fra-
mework has been viewed as beneficial in ensuring that programmes meet
appropriate standards, there have been concerns that this may limit the way in
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which this approach is able to address local need (Siering, 2008). The Dutch
approach of ‘incremental’ implementation (Helderman et al., 2005), starting out
with a select set of pilots experimenting with bundled payment and that are
being evaluated for subsequent roll-out may be regarded as an approach that
combines centrally defined requirements and local autonomy, although it should
be noted that national roll-out was advocated by the government before eva-
luation findings were available.
Ham (2003) has highlighted how competing pressures on organisations that
arise from policies initiated by healthcare reformers on one hand and established
ways of delivery, on the other, are likely to result in a gap between policy intent
and actual implementation (Ham, 2003). A critical role has to be played by pro-
fessionals, who exert a large degree of control in healthcare organisations such as
primary care practices and hospitals. Failure to engage them in the reform process is
likely to hamper sustainable change. Indeed, as work on ‘chains of care’ in Sweden
has demonstrated, approaches that engaged professionals, or were indeed initiated
by professionals themselves, succeeded in developing improved interorganisational
and interprofessional coordinated structures, whereas those initiated top-down
by councils did not (Ahgren and Axelsson, 2007). However, a supportive policy
environment was also found to be critical for success.
Fundamentally, it is, however, important to highlight that DMPs in Germany and
Austria did not fundamentally alter (or indeed challenge) existing structures in the
healthcare system. Services continue to be provided within the existing delivery
structure, comprising family physicians, specialists in private practice and hospitals.
The integration of non-medical health professionals into the care system, which has
led to considerable improvements in chronic care elsewhere, has only recently been
pursued, although remaining limited to certain settings. In Germany, although
wider use of nurses was considered and supported by the German nurses associa-
tion as a means to strengthen the role of nurse practitioners, other stakeholders, in
particular family physicians and their associations, were concerned about intro-
ducing another layer of care as well as losing control over the provision of medical
care. It is interesting to note, in this context, that the role of nurses in the Dutch care
groups, although prominent, has been reduced somewhat compared to the model
that informed their development (Klein-Lankhorst and Spreeuwenberg, 2008).
Here, the specialist diabetes nurse acted as liaison between the hospital and primary
care for all patients and indeed acted as consultant to the GP who was responsible
for the management of diabetes patients with low intensity needs. In 2007, the
model was transformed into the diabetes care group by the Regional General
Practitioners Organization in Maastricht/Heuvelland region. Thus, professional
resistance to change remains in a challenge in all systems.
Finally, one of the greatest challenges for the systems reviewed here remains
the development of a system-wide model of care for patients with chronic dis-
ease. As noted earlier, disease-specific approaches such as disease management
programmes are ill-suited to meet the needs of the typical patient in primary care
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who frequently has multiple health problems with complex needs (Nolte and
McKee, 2008a, 2008b). The Dutch care groups, although disease-focused, are
envisaged as multidisciplinary care teams and, through stratification of patients
according to severity and required care intensity, may go some way to meeting
the requirements of those with multiple health problems. However, more generalist
approaches such as the integrated care contracts implemented in Germany are
potentially better equipped to respond more complex patient needs, yet the evi-
dence as to their effect within the German healthcare system remains poorly
understood. There is a need for more systematic evaluation of new models of care
as a means to inform the development of efficient and effective interventions to
address the growing burden of chronic conditions in Europe and elsewhere.
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